Medicines for Malaria Venture (MMV) Joins The Pool for Open Innovation Against Neglected Tropical Diseases
Released on: September 03, 2010, 9:12 am
Author:
Global Health Progress
Industry: Pharmaceuticals
Global Health Progress (GHP) is pleased to highlight the
announcement that the not-for-profit public-private partnership
Medicines for Malaria Venture (MMV) will became the first product
development partnership (PDP) to contribute intellectual property to
The Pool for Open Innovation against Neglected Tropical Diseases (The
Pool).
MMV joined GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts
Institute of Technology (MIT) in providing intellectual property to The Pool.
Discussing the decision, Professor Patrick Nef, Executive Vice President of Business
Development at MMV, states, "In this way we hope to make fully available the
know-how and technologies, assembled by MMV against malaria, for the research and
development of innovative and efficacious treatments for other neglected diseases.”
By emphasizing a more accessible approach to intellectual property and know-how, The
Pool facilitates access to patents and/or technologies for organizations that want
to conduct research on treatments and motivates innovative and efficient drug
discoveries and developments for neglected diseases.
The Pool is administered by BIO Ventures for Global Health (BVGH). It’s accessible
to industry, non-profit institutions, and academic researchers who conduct research
and drug development activities that deliver real benefits for patients in the least
developed countries of the world.
Global Health Progress echoes the sentiment that MMV's contribution of patents to
The Pool, resulting from its research for new antimalarials, is an important
milestone from an organization that plays a major role in leading the development of
new therapeutics for malaria.
Global Health Progress supports the continuing partnership between not-for-profit
public-private partnerships and research-based biopharmaceutical companies as a way
to fight neglected tropical disease through targeted research and development (R&D),
improving access to critical medicines and providing key intellectual property.
About Global Health Progress:
Global Health Progress provides a platform for companies, governments, public health
leaders, universities, foundations, and other stakeholders to share experiences and
best practices and to forge new partnerships. Global Health Progress also supports
efforts to raise awareness and mobilize resources to address health challenges in
the developing world by bringing local leaders together with international health
experts, policymakers, donor governments, and the private sector.
On the Web:
www.globalhealthprogress.org
Twitter: twitter.com/globalhealth
Facebook: facebook.com/group.php?gid=35156473766
Linked-in: linkedin.com/groups?home=&gid=2972068
Contact Details: Mark Grayson
(202) 835-3460
MGrayson@phrma.org
Back to previous page
Home page
Submit your press release
2025
